9-sulfonyl-9H-purine derivatives, and preparation method and use thereof

A technology of sulfonyl and derivatives, applied in the field of chemical medicine, can solve problems such as high treatment costs, serious side effects, and decreased replication ability of clemizole hydrochloride-resistant virus strains

Active Publication Date: 2013-01-02
SICHUAN UNIV
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The traditional standard regimen approved by the FDA for the treatment of chronic hepatitis C is the combined application of PEG-interferon-α and ribavirin, which has the following problems: ①. Low effective rate; ②. Long treatment cycle and high treatment cost ; ③. Toxic and si...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 9-sulfonyl-9H-purine derivatives, and preparation method and use thereof
  • 9-sulfonyl-9H-purine derivatives, and preparation method and use thereof
  • 9-sulfonyl-9H-purine derivatives, and preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] The synthesis of embodiment 1 intermediate 6-dimethylaminopurine

[0086]

[0087] Dissolve 0.465g (3mmol) of 6-chloropurine in ethanol, then add 1.25g (9mmol) of potassium carbonate and 0.725g (9mmol) of dimethylamine hydrochloride successively, and then heat to reflux for 12h. After the reaction is completed, the solvent is distilled off under reduced pressure. The remaining solid was suspended in water and stirred for 2 hours, and then filtered to obtain the product 6-dimethylaminopurine with a net weight of 0.392 g and a yield of 80.05%. Purity (HPLC) ≥ 94%

[0088] 1 H-NMR (400MHz, DMSO-D6) δ: 2.47(s, 6H, N(CH 3 ) 2 ), 7.96(s, 1H), 8.38(s, 1H), 13.71(s, 1H).

Embodiment 2

[0089] The synthesis of embodiment 2 intermediate 6-diethylaminopurine

[0090]

[0091] According to the preparation method of the intermediate 6-dimethylaminopurine, the raw materials were replaced with 6-chloropurine and diethylamine, washed and filtered after reaction to directly obtain 6-diethylaminopurine with a yield of 85.37%. Purity (HPLC) > 95%.

[0092] 1 H-NMR (400MHz, DMSO-D6) δ: 1.33(t, 6H, -CH 3 ), 1.33 (m, 2H, -CH 2 -), 7.97(s, 1H), 8.40(s, 1H), 13.66(s, 1H).

Embodiment 3

[0093] The synthesis of embodiment 3 intermediate 6-morpholino purine

[0094]

[0095] According to the preparation method of the intermediate 6-dimethylaminopurine, the raw materials were replaced with 6-chloropurine and morpholine, washed and filtered after reaction to directly obtain 6-morpholinopurine with a yield of 89.42%. Purity (HPLC) > 96%.

[0096] 1 H-NMR (400MHz, DMSO-D6) δ: 3.71(s, 4H, O(CH 2 ) 2 ), 4.21(s, 4H, -N(CH 2 ) 2 ), 8.14(s, 1H), 8.23(s, 1H), 13.07(s, 1H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Solubilityaaaaaaaaaa
Login to view more

Abstract

The invention relates to 9-sulfonyl-9H-purine derivatives, and a preparation method and a use thereof, and belongs to the chemical medicine field. The structure of the 9-sulfonyl-9H-purine derivatives is represented by formula I, is obtained on the basis of massive screening in the invention, has an anti-HCV (hepatitis C virus) activity, and provides a new choice for the development and the application of anti-HCV medicines.

Description

technical field [0001] The invention relates to a 9-sulfonyl-9H-purine derivative, a preparation method and application thereof, and belongs to the field of chemical medicine. Background technique [0002] Chronic hepatitis C, a chronic liver disease caused by the hepatitis C virus (HCV), is the leading cause of cirrhosis and liver cancer, and is currently the leading cause of liver transplantation. According to the survey of the World Health Organization (WHO) in 1999, about 3% of people (170 million people) in the world are infected with HCV (J.Viral.Hepat.1999, 6: 35-47), and the infection rate in China is about 3.2% (40 million people) (Lancet Infect. Dis. 2005.5: 558-67), and the number of infected people tends to increase year by year. After the incubation period of 10-20 years, about 80% of these HCV-infected people will develop into chronic hepatitis C, 20% will further develop into liver cirrhosis, and 1%-4% will eventually develop into liver cirrhosis. Progressio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D473/40C07D473/38C07D473/34C07D473/30A61K31/52A61K31/5377A61P31/14A61P1/16
CPCC07D473/30A61K31/52C07D473/40C07D473/38C07D473/34A61K31/5377A61P1/16A61P31/14
Inventor 余洛汀魏于全
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap